GDF5 and Osteopenia: This suggests that a BMP-2 dose of ~250 μg may be sufficient for long-term induction of bone formation in the present system, close to the 100 μg recommended for BMP-2, GDF-5 and its mutant BB-1 in the sheep defect model of lumbar osteopenia [24–26].